Logo image of LDL

Lydall Inc (LDL) Stock Fundamental Analysis

NYSE:LDL - New York Stock Exchange, Inc. -

62.09  +0.01 (+0.02%)

After market: 62.09 0 (0%)

Fundamental Rating

2

LDL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 127 industry peers in the Machinery industry. Both the profitability and financial health of LDL have multiple concerns. LDL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LDL was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -0.07%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 1.94%
PM (TTM) -0.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for LDL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

LDL has an Altman-Z score of 3.11. This indicates that LDL is financially healthy and has little risk of bankruptcy at the moment.
LDL has a Debt/Equity ratio of 0.91. This is a neutral value indicating LDL is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 3.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LDL has a Current Ratio of 1.95. This is a normal value and indicates that LDL is financially healthy and should not expect problems in meeting its short term obligations.
LDL has a Quick Ratio of 1.48. This is a normal value and indicates that LDL is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.48

More info and screens

6

3. Growth

3.1 Past

LDL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1900.00%, which is quite impressive.
The Revenue has grown by 16.23% in the past year. This is quite good.
Measured over the past years, LDL shows a small growth in Revenue. The Revenue has been growing by 7.81% on average per year.
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%285.19%
Revenue 1Y (TTM)16.23%
Revenue growth 3Y3.04%
Revenue growth 5Y7.81%
Sales Q2Q%51.71%

3.2 Future

LDL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 406.52% yearly.
Based on estimates for the next years, LDL will show a quite strong growth in Revenue. The Revenue will grow by 11.38% on average per year.
EPS Next Y9392%
EPS Next 2Y939.47%
EPS Next 3Y541.91%
EPS Next 5Y406.52%
Revenue Next Year18.7%
Revenue Next 2Y11.55%
Revenue Next 3Y11.26%
Revenue Next 5Y11.38%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LDL Yearly Revenue VS EstimatesLDL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LDL Yearly EPS VS EstimatesLDL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 68.99, the valuation of LDL can be described as expensive.
LDL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.51.
Based on the Price/Forward Earnings ratio of 29.27, the valuation of LDL can be described as expensive.
LDL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.09.
Industry RankSector Rank
PE 68.99
Fwd PE 29.27
LDL Price Earnings VS Forward Price EarningsLDL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.25
LDL Per share dataLDL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LDL's earnings are expected to grow with 541.91% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y939.47%
EPS Next 3Y541.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LDL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Lydall Inc

NYSE:LDL (9/30/2021, 8:04:00 PM)

After market: 62.09 0 (0%)

62.09

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners4.69%
Ins Owner Change0%
Market Cap1.12B
Analysts0
Price Target63.34 (2.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 68.99
Fwd PE 29.27
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 4.07
P/tB N/A
EV/EBITDA 18.25
EPS(TTM)0.9
EY1.45%
EPS(NY)2.12
Fwd EY3.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS48.02
BVpS15.26
TBVpSN/A
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.94%
PM (TTM) -0.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.48
Altman-Z 3.11
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%285.19%
EPS Next Y9392%
EPS Next 2Y939.47%
EPS Next 3Y541.91%
EPS Next 5Y406.52%
Revenue 1Y (TTM)16.23%
Revenue growth 3Y3.04%
Revenue growth 5Y7.81%
Sales Q2Q%51.71%
Revenue Next Year18.7%
Revenue Next 2Y11.55%
Revenue Next 3Y11.26%
Revenue Next 5Y11.38%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A